National Path Lab
Liver & Gastrointestinal Diseases

Celiac Disease

Celiac disease is an immune-mediated disorder triggered by gluten exposure in genetically susceptible individuals. It can cause intestinal inflammation, malabsorption, anemia, nutritional deficiencies, and gastrointestinal symptoms.

Celiac serology should be interpreted in the context of symptoms and dietary gluten exposure. Further evaluation, including specialist assessment and sometimes intestinal biopsy, may be required to confirm the diagnosis.

At National Path Lab (NPL), celiac disease serological testing is available to support the initial evaluation of suspected celiac disease.

Tests available
4
Tests available
Health package
1
Health package

Tests Available at NPL

TISSUE TRANSGLUTAMINASE (TTG) ANTIBODY, IGA

Turn Around Time
SAMPLE BY TUE & FRI 8: 00 AM REPORT ON SAME DAY EVENING

Rs. 2200

ENDOMYSIAL ANTIBODY IGA, IFA

Turn Around Time
SAMPLE BY MON & FRI 8:00 AM, REPORT ON SAME DAY EVENING

Rs. 4200

IMMUNOGLOBULIN IGA

Turn Around Time
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY

Rs. 1500

IMMUNOGLOBULIN IGG

Turn Around Time
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY

Rs. 1500

About Celiac Disease

Causes & Risk Factors

Celiac disease results from an immune reaction to gluten in genetically susceptible individuals:

•  Genetic susceptibility — certain genetic markers (HLA-DQ2/DQ8) are present in nearly all people with celiac disease, though having these markers alone does not mean a person will develop the condition.

•  Family history of celiac disease increases individual risk.

•  Gluten exposure — the disease is triggered specifically by dietary gluten in genetically susceptible individuals.

•  Certain autoimmune conditions (such as type 1 diabetes or autoimmune thyroid disease) are associated with increased celiac disease risk.

Symptoms & When to Test

Celiac disease can present with classic gastrointestinal symptoms or with more subtle, non-gastrointestinal features, making it sometimes challenging to recognize.

•  Chronic diarrhea

•  Abdominal bloating

•  Abdominal pain

•  Weight loss

•  Iron deficiency anemia

•  Fatigue

•  Poor growth in children

•  Nutritional deficiencies

When Should You Consider Testing?

Testing is appropriate for chronic gastrointestinal symptoms, unexplained iron deficiency anemia, unexplained nutritional deficiencies, poor growth in children, or in individuals with a family history of celiac disease or an associated autoimmune condition.

Why Tests Are Combined

tTG-IgA is used as the initial serological test because it offers a good balance of sensitivity and specificity for celiac disease, but Total IgA is tested alongside it because IgA deficiency (present in a small percentage of the population) can cause a false-negative tTG-IgA result.

In patients with IgA deficiency, IgG-based celiac testing is used instead, since relying on tTG-IgA alone in this situation would risk missing the diagnosis entirely.

EMA-IgA may be added as a highly specific supportive test in certain situations, since its high specificity can help increase diagnostic confidence, particularly when initial results are borderline or when confirmatory evidence is needed before considering more invasive testing such as biopsy.

Tests Available at NPL

Test Code

Test

Clinical Relevance

I0094

tTG-IgA (Tissue Transglutaminase IgA)

Commonly used as an initial serological test for celiac disease.

B0093

Total IgA

Helps identify IgA deficiency, which can affect interpretation of IgA-based celiac tests.

I0031

ENDOMYSIAL ANTIBODY IGA, IFA

May be used as a highly specific supportive serological test.

B0095

IgG Total

Helps identify IgG deficiency, relevant when considering IgG-based celiac testing in IgA-deficient patients.

Preparation requirements vary by specific test — please follow the instructions provided by your doctor or NPL for the tests ordered.

Home Sample Collection

NPL offers convenient home sample collection for Celiac Disease blood tests, so you don't need to visit a lab in person.

→ Book your test online, via the NPL app, or by calling +977 1 5970147 and select a convenient time slot for home sample collection.

→ A certified and experienced NPL phlebotomist visits your home at the scheduled time, following strict hygiene and safety protocols.

→ Your sample is transported under controlled, monitored conditions to NPL's NABL ACCREDITED UNDER ISO 15189:2022 laboratory for processing.

→ Your digital report is delivered securely to your phone or email, along with access to download and share it as needed.

When to See a Doctor

•  Chronic diarrhea, bloating, or abdominal pain

•  Unexplained iron deficiency anemia

•  Unexplained weight loss or nutritional deficiencies

•  Poor growth in a child

•  Family history of celiac disease or an associated autoimmune condition

Medical Disclaimer

Laboratory tests support the initial evaluation of celiac disease but do not independently confirm the diagnosis. Further evaluation, including specialist assessment and possibly biopsy, may be required. This content is for general information only and is not a substitute for medical advice, diagnosis, or treatment.

Related Packages

CELIAC PANEL SCREENING

Test Includes
3 Tests

Rs. 5000

Frequently Asked Questions

tTG-IgA is commonly used as an initial serological test, together with Total IgA to identify possible IgA deficiency that could affect test accuracy.
No, celiac antibody testing usually does not require fasting.
No — you should continue eating gluten as normal before testing, since stopping gluten beforehand can cause a false-negative result. Discuss any planned dietary changes with your doctor before testing.
Not always definitively on its own — a positive result typically leads to further evaluation, which may include specialist assessment and intestinal biopsy, to confirm the diagnosis.
In some cases, particularly in children with strongly positive antibody results and a specific genetic marker, diagnosis without biopsy may be possible, but this determination should be made by a specialist based on established criteria.